Transient ischemic attack due to an atrial septal defect

Crosca, Sergio; Torrisi, Giuseppe; Calvagna, Giuseppe Mario; Patanè, Salvatore

doi:10.1016/j.ijcard.2014.03.062

Cited by 3 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[2,3] Strokes with of indefinite causes account for approximately 30% to 40% of all strokes, even after a comprehensive work-up, and are regarded as cryptogenic strokes. [4] An increasing number of studies have shown that PFO has a significant positive correlation with the risk of having a CS, [5,6] which may possibly be due to paradoxical embolism development. [7] However, the probability of detecting the thrombus in clinical practice is extremely low, with most of the diagnoses of paradoxical embolisms being speculative.…”

Section: Introductionmentioning

confidence: 99%

Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale

Zhao

Liu²,

Zhang³

et al. 2017

Medicine

View full text Add to dashboard Cite

Background: Amplatzer occluder and Cardio-O-fix occluder are currently used in percutaneous closure of patent foramen ovale. However, there is still a lack of relevant reports comparison the differences between them. The aim of this study was to evaluate the short-term and mid-term safety and efficacy of the Cardi-O-fix occluder in preventing recurrent cerebrovascular events in patients with a patent foramen ovale (PFO).Methods: We enrolled 246 patients (105 men) with a PFO from May 30, 2013 to March 30, 2015 in this single-center prospective study. All patients were treated by PFO interventional closure, with the Cardi-O-fix PFO occluder being used in 180 patients and the Amplatzer PFO occluder being utilized in the remaining 66 patients. After the procedure, we verified the safety and efficacy of different devices using contrast transthoracic echocardiography.Results: Neither recurrent stroke nor death was encountered during the follow-up of 12 months. Transient ischemic attack (TIA) was noted in 2 patients (1.1%) in the Cardi-O-fix PFO occluder group, and 1 patient suffered from TIA (1.5%) in the Amplatzer PFO occluder group. Among them, only 1 patient exhibited a small right to left shunt (RLS). There was no statistical difference in recurrent cerebral ischemic events. Three cases of paroxysmal atrial fibrillation were observed in the Cardi-O-fix PFO occluder group. One reverted spontaneously to sinus rhythm and the other 2 cases had pharmacologic conversion to sinus rhythm. One case of paroxysmal atrial fibrillation occurred in the Amplatzer group, which underwent pharmacologic conversion to sinus rhythm. There was no significant difference between the 2 groups regarding incidence of arrhythmia. No occluder translocation, erosion, pericardial effusion, and puncture site bleeding were observed in the 2 groups within 12 months of follow-up. The complete closure rates of the Cardi-O-fix and Amplatzer PFO occluder devices at the 12 months after the procedure were 73.9% and 63.6%, respectively, and the effective closure rates were 90.6% and 86.4%, respectively. There was no statistically significant difference in the complete closure rate and effective occlusion rate (P > 0.05) between the devices.Conclusions: There was no significant difference in the short-and mid-term efficacy and safety between the Cardi-O-fix PFO occluder and Amplatzer PFO occluder. The efficacy and safety of the Cardi-O-fix occluder were comparable to those of the Amplatzer PFO occluder.Abbreviations: CS = cryptogenic stroke, PFO = patent foramen ovale, RLS = right to left shunt, TIA = transient ischemic attack.

show abstract

Section: Introductionmentioning

confidence: 99%

Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale

Zhao

Liu²,

Zhang³

et al. 2017

Medicine

View full text Add to dashboard Cite

show abstract

“…Increasing evidence suggests that the role of infective endocarditis antibiotic prophylaxis remains a dark side of the cardio-oncology prevention [1,11,12] as well as the role of the thromboembolism prophylaxis [19]. Certain congenital cardiac defects may go undetected for several years due to lack of symptoms and signs [36][37][38][39][40][41][42][43][44][45][46][47]. We present a case of a chance finding of an important atrial septal defect in a 73-year-old Italian woman evaluated for an oncosurgery intervention.…”

mentioning

confidence: 99%